Central Asia Drug Action Programme –Phase 6 (CADAP 6)
CADAP 6 supports the drug demand aspect of a balanced drug policy in line with the EU Drug Strategy 2013-2020 and the EU Central Asia Drug Action Plan 2014-2020 and assists the Central Asian governments in strengthening the capacity of national agencies to deal with the drug phenomenon in a comprehensive, integrative, and sustainable manner. All programme activities under CADAP 6 focus both on national and regional capacity building by providing policy advice and technical assistance, monitoring of the drugs situation, prevention, drug treatment and harm reduction services.
Start: 01 April 2022
Duration: 36 months
Implemented by a Consortium of EU institutions: Trimbos Institute (the Netherlands), ResAd (Czech Republic), National Bureau for Drug Prevention (Poland), and Frankfurt University of Applied Sciences (Germany) led by Deutsche Gesellschaft für Internationale Zusammenarbeit (GIZ) GmbH.